| Literature DB >> 27050914 |
Emma-Lee Bourne1, James Dimou2.
Abstract
Aspergillus species are emerging as a significant cause of pneumonia mortality in immune compromised hosts, with haematological spread being a rare and life-threatening complication. The central nervous system (CNS) as a site for extrapulmonary spread is rarer still. We report a case of CNS disseminated aspergillosis in a patient treated with corticosteroids and infliximab, an immunomodulatory agent commonly used in the treatment of inflammatory bowel disease, and review the available literature regarding this rare pathology. CrownEntities:
Keywords: Aspergillus; Central nervous system; Immunocompromised; Infliximab; Pneumonia
Mesh:
Substances:
Year: 2016 PMID: 27050914 DOI: 10.1016/j.jocn.2016.02.009
Source DB: PubMed Journal: J Clin Neurosci ISSN: 0967-5868 Impact factor: 1.961